Analysts at Wedbush provided their outlook on IMAX Corporation (NYSE:IMAX) ahead of the company’s Q3 results, which are expected to be reported on Oct 28. The analysts believe the company is best positioned within the theatrical exhibitions as its success is solely dependent on blockbusters and not on the overall release slate. The company’s theatres typically play only the first week or two of these blockbusters, so is largely insulated from shrinking theatrical windows. As attendance compresses closer to a film’s opening, the company becomes a more prominent screen option, driving market share gains, as it continues to expand its footprint globally.
The brokerage now expects Q3 revenue of $55 million, compared to its previous estimate of $65 million and Street estimate of $57 million.